Tablet Health Review

Tablet Health: a transparent compounder with one big asterisk

Tablet Health is one of the few compounded GLP-1 telehealth services that will actually tell you which pharmacies fill your prescription, and it pairs that openness with a genuinely uncommon perk: an oral version of both semaglutide and tirzepatide, not just the usual weekly shot. If you want needle-free dosing and you like knowing where your medication comes from, Tablet earns a real look. But it is also a very young operation that hides some basic facts a careful patient would want before paying, so we hold it at LOW confidence. This review walks through both sides honestly.

How the pricing actually works

Tablet uses simple per-product monthly pricing rather than a tiered subscription. Oral semaglutide is the cheapest entry point, and injectable tirzepatide sits at the top of the range, with the headline rate landing at $179 a month. That puts Tablet in the mid-tier of compounded GLP-1 telehealth — close to the category median of $169 — so it is neither a bargain-basement teaser nor a premium concierge price. There is no long-term contract; the model is cancel-anytime, which is exactly what you want from a service this new.

The honest catch: the price you see is a 'starting at' anchor. Tablet does not publish its dose-by-dose pricing — the per-dose breakdown only appears after you complete the intake quiz. GLP-1 doses escalate over your first few months, and most compounders charge more at higher doses, so budget for that. You cannot confirm the full ladder before you enroll, which is a real transparency gap on the one thing patients most need to plan around.

The medications — and the rare oral option

Tablet offers compounded semaglutide and compounded tirzepatide, each available as a weekly injection or as an oral formulation. The oral route is the standout. Most compounded telehealth brands are injection-only, so being able to choose a non-injectable version of either molecule is genuinely unusual and may be the single best reason to pick Tablet if needles are your dealbreaker.

Be clear-eyed about what these are. They are compounded preparations, not FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound. Compounded drugs are not evaluated by the FDA for safety or efficacy. Tablet also operates after the shortage-era window closed — the FDA ended its tirzepatide enforcement discretion in March 2025 and semaglutide in May 2025 — so the legal footing for ongoing compounded GLP-1 sales now rests on each pharmacy's patient-specific 503A exemption. That is standard for the post-shortage market, but it is not something we can independently verify for you.

What genuinely sets Tablet apart: it names its pharmacies

Most compounders treat their fulfillment pharmacies as a secret. Tablet names four of them outright, which is the kind of transparency we wish were standard:

• The Pharmacy Hub — Miami, FL
• Epiq Scripts — Richardson, TX (state-licensed 503A, NPI on file)
• Dr. TelX LLC — Kennewick, WA
• Emerad Compounding Pharmacy — Tampa, FL

We checked all four against the FDA warning-letter database and found none flagged as of our last review. Tablet is also LegitScript Certified (certificate 70456), an independent screening that weeds out the worst actors in online pharmacy. Together, the named pharmacies plus LegitScript are the backbone of Tablet's credibility — and the reason it clears our bar to be listed at all.

Why we hold Tablet at LOW confidence

This is where we have to be blunt. Several basics that established providers publish, Tablet does not:

• No states list. The site never says where it can legally treat you — you have to finish the intake quiz to find out if you're even eligible.
• No named humans. There is no founder, CEO, medical director, or pharmacist-in-charge identified anywhere on the site, its terms, or in search. For a service prescribing GLP-1s, that absence of accountable clinical leadership is a meaningful trust gap.
• No phone, no BBB. Support is email-only, with no published phone number and no Better Business Bureau profile we could find.
• A pharmacy that isn't open yet. Tablet markets its own Queens, NYC pharmacy as 'opening soon' — meaning every prescription today routes through the four outside partners above.
• Very new, and a little sloppy. The footer carries a 2026 copyright, and the site cites its own customer count two different ways on the same page. Treat the marketing numbers with a grain of salt.

None of these is proof of a bad actor — but stacked together they're why we won't rank Tablet among our top picks until it publishes a state list, names a responsible clinician or pharmacist, or its own pharmacy opens with a verifiable license. You can read how we weigh these factors in our scoring methodology.

Who should choose Tablet — and who should skip it

Consider Tablet if an oral GLP-1 is the feature you most want, if you specifically value knowing which pharmacy fills your script, and if a LegitScript seal plus a no-commitment cancel policy is enough reassurance to try a newer brand. The mid-tier price and lack of lock-in make it low-risk to test for a month.

Skip it if you want a documented, established provider with named medical leadership, published state coverage, phone support, and a multi-year track record. If you need to know up front exactly what every dose will cost, or you're uneasy about a company that won't tell you where it operates or who runs it, a more mature competitor is the safer call.

Bottom line

Tablet Health gets two things right that much of the category gets wrong — it names its compounding pharmacies and it offers oral as well as injectable GLP-1s — and it's LegitScript Certified with fair, cancel-anytime pricing. Those are real strengths. But it's a brand-new operation that withholds its state coverage, names no accountable clinician, runs email-only support, and gates per-dose pricing behind a quiz. Worth a trial for the right needle-averse, transparency-minded patient; not yet a provider we'd send someone who wants a proven, fully accountable option.

For a side-by-side, DudeMeds ($175/month) and Bodybuilding Health+ ($179/month) are the most comparable options to weigh against Tablet Health.